REcurrent VEnous thromboembolism Risk Stratification Evaluation (REVERSE): Long Term Follow-up to Define if Lifelong Anticoagulation is Required in High Risk Patients with a First Unprovoked Venous Thromboembolism

复发性静脉血栓栓塞风险分层评估 (REVERSE)：长期随访以确定首次无端静脉血栓栓塞的高危患者是否需要终身抗凝

• 批准号: 179363
• 负责人: Rodger Marc A
• 金额: $ 6.99万
• 依托单位: Ottawa Hospital Research Institute
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2008
• 资助国家: 加拿大
• 起止时间: 2008-09-01 至 2009-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=179363&lang=en
• 关键词: High Risk; Long-Term Outcomes; Prospective Cohort Study; Recurrent Venous Thromboembolism (Vte); Risk Stratification; Unprovoked Venous Thromboembolism

Blood clots in leg veins (deep vein thrombosis) or lung arteries (pulmonary embolism) that arise without a clear cause (i.e. unexplained) are collectively called "unprovoked venous thromboembolism"(VTE). There is evidence that some of these patients with

腿部静脉（深静脉血栓形成）或肺动脉（肺栓塞）中的血块出现没有明确的原因（即， 原因不明）统称为“无端静脉血栓栓塞症”（VTE）。有证据表明，其中一些 患者